Growth inhibition of human SW626 cells implanted intraperitoneally to NCr nu/nu mouse at 4.39 to 35.1 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted subcutaneously to NCr nu/nu mouse at 4.39 to 35.1 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted intraperitoneally to NCr nu/nu mouse at 7.13 to 28.5 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted subcutaneously to NCr nu/nu mouse at 7.13 to 28.5 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted intraperitoneally to NCr nu/nu mouse at 72.6 to 290.7 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted subcutaneously to NCr nu/nu mouse at 72.6 to 290.7 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted intraperitoneally to NCr nu/nu mouse at 128 to 512 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells implanted subcutaneously to NCr nu/nu mouse at 128 to 512 umol/kg, ip administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells xenografted in NCr nu/nu mouse at 3.75 to 30 mg/kg, ip once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells xenografted in NCr nu/nu mouse at 3.75 to 30 mg/kg, sc once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells xenografted in NCr nu/nu mouse at 25 to 100 mg/kg, ip once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
Growth inhibition of human SW626 cells xenografted in NCr nu/nu mouse at 25 to 100 mg/kg, sc once daily administered from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test